Dr. Haitham Shaheen, Swansea bay university health board, United Kingdom
Dr. Haitham Shaheen is a highly accomplished medical oncology consultant with a distinguished academic and clinical background in oncology. Born on September 30, 1987, he currently serves as a Consultant in Medical Oncology at Somerset NHS Foundation Trust, UK, where he independently manages cancer patients, prescribes systemic anticancer therapies (SACT), and actively participates in multidisciplinary teams (MDTs). Previously, he held academic and clinical positions at Suez Canal University Hospital in Egypt, advancing from Assistant Lecturer to Consultant and Lecturer of Clinical Oncology. He holds an MD in Clinical Oncology, MRCP-UK, and certification from the European Society of Medical Oncology (ESMO). Dr. Shaheen has authored multiple high-impact publications on prostate cancer, pediatric lymphoma, and radiotherapy, and has presented his research internationally. A certified expert educator and active contributor to medical education and hospital training programs, he also held leadership roles in radiotherapy and digital transformation initiatives. His dedication to oncology, both clinically and academically, has earned him recognition for his contributions to research, education, and patient care.
Professional Profile:
SCOPUS
Summary of Suitability: Dr. Haitham Shaheen – Research for Best Researcher Award
Dr. Haitham Shaheen is a highly accomplished clinical oncologist and researcher whose work demonstrates a strong blend of academic rigor, clinical excellence, and impactful research in oncology. With dual MD degrees in Clinical Oncology, MRCP-UK, and ESMO certification, he possesses an exceptional academic foundation. His recent publications in high-impact journals such as Brachytherapy and the International Journal of Radiation Oncology, Biology, Physics reflect his deep engagement with evidence-based cancer treatment and translational research. Dr. Shaheen’s focus on prostate cancer outcomes and innovative treatment safety showcases a commitment to improving oncological care through research. In his current role as a consultant at the Somerset NHS Foundation Trust, he continues to integrate clinical practice with research, underscoring his suitability for the Best Researcher Award.
🎓 Education
-
🩺 Bachelor of Medicine and Surgery – Suez Canal University, Egypt (Nov 2010)
-
📘 MD in Clinical Oncology – Suez Canal University (March 2016)
-
🎓 MD (Highest Academic Medical Degree in Egypt) – Suez Canal University (March 2021)
-
🇬🇧 MRCP (UK) – Royal College of Physicians (Jan 2022)
-
🌍 ESMO Certificate – European Society of Medical Oncology (Nov 2022)
💼 Work Experience
-
👨⚕️ Consultant, Medical Oncology – Somerset NHS Foundation Trust, UK (Sep 2023 – Present)
-
👨🏫 Lecturer & Consultant, Clinical Oncology – Suez Canal University Hospital, Egypt (Mar 2021 – Sep 2023)
-
🧑⚕️ Assistant Lecturer & Specialist, Clinical Oncology – Suez Canal University Hospital (Mar 2016 – Mar 2021)
-
🏥 Resident, Clinical Oncology – Suez Canal University Hospital (2012 – 2016)
-
🩺 Internship – Suez Canal University Hospital (2011 – 2012)
🏆 Achievements, Awards & Publications
-
📝 First Author –
-
Voluntary DIBH with VMAT in Pediatric Hodgkin’s Lymphoma, Future Oncology Journal (Jan 2023)
-
Systematic Review on Prostate Cancer Outcomes, IJROBP (Red Journal) (Oct 2023)
-
🤝 Co-author –
-
Safety of HDR Brachytherapy in Prostate Cancer, Brachytherapy Journal (Dec 2023)
-
Oncologist Perceptions on Cancer Patient Vaccination, IJCBR (Mar 2022)
-
Pediatric Radiotherapy Utilization Rate, Radiotherapy and Oncology (2021)
-
🎤 Oral Presentations on VMAT and DIBH in Mediastinal Lymphoma
-
📅 Conference Organizer & Secretary – 1st and 2nd Oncology Conferences, Suez Canal University (2018, 2019)
Publication Top Notes:
Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series